株式会社ＦＸプライムbyＧＭＯに対する検査結果に基づく勧告について
https://www.fsa.go.jp/sesc/news/c_2020/2020/20200804-3.htmlBundle the HTML, screenshot, summaries, and metadata into one ZIP file.
株式会社ＦＸプライムbyＧＭＯに対する検査結果に基づく勧告について
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it, similar to archive wrappers such as Web Gyotaku.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page reports a recommendation issued by the Securities and Exchange Surveillance Commission against FX Prime by GMO Co., Ltd. based on inspection findings. The company displayed "No slippage (0%)" in web and magazine advertisements from September 2017 to November 2019 for its foreign exchange margin trading tool. However, the company's system was actually unable to eliminate slippage (the difference between order and execution prices), and the company had received customer reports of slippage occurring. Despite this, the company failed to conduct adequate verification and made false representations, violating the Financial Instruments and Exchange Act Article 37, Paragraph 2.
